Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Human Genetics|December 22, 1999
SH2D1A mutation analysis for diagnosis of XLP in typical and atypical patientsL Yin, V Ferrand, M F Lavoué, et al.
The New England Journal of Medicine|August 7, 1997
Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation GroupE Gluckman, V Rocha, A Boyer-Chammard, et al.
Bone Marrow Transplantation|August 5, 2000
Outcome of unrelated bone marrow donor searches in 174 children resulting in 45 patients transplanted in the HLA-matched and -mismatched situationG Souillet, S Rey, Y Bertrand, et al.
American Journal of Human Genetics|January 23, 1999
Linkage of familial hemophagocytic lymphohistiocytosis to 10q21-22 and evidence for heterogeneityR Dufourcq-Lagelouse, N Jabado, F Le Deist, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 12, 2008
Invasive aspergillosis and allogeneic hematopoietic stem cell transplantation in children: a 15-year experienceN Crassard, H Hadden, C Pondarré, et al.
Bone Marrow Transplantation|December 1, 1996
Juvenile myelomonocytic leukemia: analyses of treatment results in the EORTC Children's Leukemia Cooperative Group (CLCG)P Lutz, I Zix-Kieffer, G Souillet, et al.
Blood|May 26, 1999
Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant GroupF Locatelli, V Rocha, C Chastang, et al.
Bone Marrow Transplantation|May 29, 2007
Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failureJ J Boelens, R F Wynn, A O'Meara, et al.
Bone Marrow Transplantation|September 9, 2004
Antileukemic and long-term effects of two regimens with or without TBI in allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemiaQ Y Dai, G Souillet, Y Bertrand, et al.
Leukemia & Lymphoma|March 14, 1998
In vivo infusion of anti-LFA-1 and anti-CD2 antibodies prevents graft failure after HLA partially incompatible bone marrow transplantation in children with high risk acute lymphoblastic leukaemiaM Cavazzana-Calvo, N Jabado, P Bordigoni, et al.
Pageof 11